undefined
EUTM file information

018700468

OVAMEX


May 8, 2022

Trademark Summary

The trademark application OVAMEX was filed by Theramex HQ UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on June 7, 2022, and it was registered by office on September 14, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on October 2, 2022. Change of name and professional address of the trademark registration was recorded on January 26, 2023. Change of name and address of the trademark registration was recorded on August 15, 2023.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Anti-fungal pharmaceutical preparations
    2. Contraceptive preparations
    3. Contraceptive sponges
    4. Chemical contraceptives
    5. Oral contraceptives
    6. Pharmaceutical preparations and substances for use in relation to women's health
    7. Pharmaceutical preparations and substances containing hormones
    8. Pharmaceutical preparations and substances in the nature of hormone replacement therapy [HRT]
    9. Pharmaceutical preparations and substances for use in relation to reproductive health
    10. Pharmaceutical preparations and substances for use in relation to contraception
    11. Pharmaceutical preparations and substances for use in relation to conception
    12. Pharmaceutical preparations and substances for use in relation to fertility
    13. Fertility enhancement preparations
    14. Pharmaceutical preparations and substances for use in relation to the treatment of infertility
    15. Pharmaceutical preparations and substances for use in endocrinology
    16. Pharmaceutical preparations and substances for use in gynaecology
    17. Pharmaceutical preparations for the treatment of menopause
    18. Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms
    19. Pharmaceutical preparations and substances for the treatment of osteoperosis
    20. Pharmaceutical preparations and substances for the alleviation of osteoperosis-related symptoms
    21. Pharmaceutical preparations and substances for the treatment of bone loss
    22. All the above being for human use.
  • The mark was filed in class 10 with following description of goods:
    1. Medical apparatus and instruments in relation to reproductive health
    2. Medical devices in relation to reproductive health
    3. Self-injectors for subcutaneous administration of pharmaceutical preparations for the treatment of infertility
    4. All the above being for human use.